These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28529580)

  • 1. MicroRNA-592 targets IGF-1R to suppress cellular proliferation, migration and invasion in hepatocellular carcinoma.
    Wang W; Zhang H; Tang M; Liu L; Zhou Z; Zhang S; Wang L
    Oncol Lett; 2017 May; 13(5):3522-3528. PubMed ID: 28529580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. microRNA-944 inhibits the malignancy of hepatocellular carcinoma by directly targeting IGF-1R and deactivating the PI3K/Akt signaling pathway.
    Lv L; Wang X; Ma T
    Cancer Manag Res; 2019; 11():2531-2543. PubMed ID: 31114322
    [No Abstract]   [Full Text] [Related]  

  • 3. MicroRNA-320a is downregulated in non-small cell lung cancer and suppresses tumor cell growth and invasion by directly targeting insulin-like growth factor 1 receptor.
    Wang J; Shi C; Wang J; Cao L; Zhong L; Wang D
    Oncol Lett; 2017 May; 13(5):3247-3252. PubMed ID: 28521431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-877 inhibits cell proliferation and invasion in non-small cell lung cancer by directly targeting IGF-1R.
    Zhou G; Xie J; Gao Z; Yao W
    Exp Ther Med; 2019 Aug; 18(2):1449-1457. PubMed ID: 31316632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-495 suppresses cell proliferation and invasion of hepatocellular carcinoma by directly targeting insulin-like growth factor receptor-1.
    Ye Y; Zhuang J; Wang G; He S; Zhang S; Wang G; Ni J; Wang J; Xia W
    Exp Ther Med; 2018 Jan; 15(1):1150-1158. PubMed ID: 29434703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pleiotropic effect of the single clustered hepatic metastamiRs miR-96-5p and miR-182-5p on insulin-like growth factor II, insulin-like growth factor-1 receptor and insulin-like growth factor-binding protein-3 in hepatocellular carcinoma.
    Assal RA; El Tayebi HM; Hosny KA; Esmat G; Abdelaziz AI
    Mol Med Rep; 2015 Jul; 12(1):645-50. PubMed ID: 25739014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-497 regulates cell proliferation in hepatocellular carcinoma.
    Ding WZ; Ni QF; Lu YT; Kong LL; Yu JJ; Tan LW; Kong LB
    Oncol Lett; 2016 Feb; 11(2):1081-1088. PubMed ID: 26893696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-138 targets SP1 to inhibit the proliferation, migration and invasion of hepatocellular carcinoma cells.
    Liu C; Zhu J; Liu F; Wang Y; Zhu M
    Oncol Lett; 2018 Jan; 15(1):1279-1286. PubMed ID: 29387246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-503 inhibits hepatocellular carcinoma cell growth via inhibition of insulin-like growth factor 1 receptor.
    Xiao Y; Tian Q; He J; Huang M; Yang C; Gong L
    Onco Targets Ther; 2016; 9():3535-44. PubMed ID: 27366090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of miR-16-5p in the proliferation and metastasis of hepatocellular carcinoma.
    Cheng B; Ding F; Huang CY; Xiao H; Fei FY; Li J
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):137-145. PubMed ID: 30657555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-10b inhibits proliferation, migration and invasion in cervical cancer cells via direct targeting of insulin-like growth factor-1 receptor.
    Hou R; Wang D; Lu J
    Oncol Lett; 2017 Jun; 13(6):5009-5015. PubMed ID: 28599502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-381 suppresses cell growth and invasion by targeting the liver receptor homolog-1 in hepatocellular carcinoma.
    Zhang Q; Zhao S; Pang X; Chi B
    Oncol Rep; 2016 Mar; 35(3):1831-40. PubMed ID: 26677080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1.
    He Y; He X
    Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-134 targets KRAS to suppress breast cancer cell proliferation, migration and invasion.
    Su X; Zhang L; Li H; Cheng P; Zhu Y; Liu Z; Zhao Y; Xu H; Li D; Gao H; Zhang T
    Oncol Lett; 2017 Mar; 13(3):1932-1938. PubMed ID: 28454346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma.
    Wu G; Zheng K; Xia S; Wang Y; Meng X; Qin X; Cheng Y
    J Exp Clin Cancer Res; 2016 Jun; 35(1):89. PubMed ID: 27259866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional activation of the IGF-II/IGF-1R axis and inhibition of IGFBP-3 by miR-155 in hepatocellular carcinoma.
    El Tayebi HM; Waly AA; Assal RA; Hosny KA; Esmat G; Abdelaziz AI
    Oncol Lett; 2015 Nov; 10(5):3206-3212. PubMed ID: 26722313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma.
    Fang F; Chang RM; Yu L; Lei X; Xiao S; Yang H; Yang LY
    J Hepatol; 2015 Oct; 63(4):874-85. PubMed ID: 25998163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-448 suppresses cell proliferation and glycolysis of hepatocellular carcinoma through inhibiting IGF-1R expression.
    Wang Y; Chen X; Yao N; Gong J; Cao Y; Su X; Feng X; Tao M
    J Gastrointest Oncol; 2022 Feb; 13(1):355-367. PubMed ID: 35284123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-145 and MicroRNA-133a Inhibited Proliferation, Migration, and Invasion, While Promoted Apoptosis in Hepatocellular Carcinoma Cells Via Targeting FSCN1.
    Wang G; Zhu S; Gu Y; Chen Q; Liu X; Fu H
    Dig Dis Sci; 2015 Oct; 60(10):3044-52. PubMed ID: 26173501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor.
    Luo M; Shen D; Zhou X; Chen X; Wang W
    Surgery; 2013 Jun; 153(6):836-47. PubMed ID: 23453369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.